- walked the public signup
- tracked the real cost
- read the fine print
Willow review
The rare one that just tells you the price and then charges it — $299 or $399, injection or tablet, no first-month bait — and the only one on my list that puts its doctors' names on a public page. It's expensive, it only works in 36 states, and it has an advertising complaint it never answered.
- HSA / FSA-eligible
- Walked the public signup
- No insurance needed
Referral link — walled off from the score
Willow at a glance
- Semaglutide
- $299/mo
- Tirzepatide
- $399/mo
- Coverage
- 36 states (published list — not AL, AK, AR, DE, KS, LA, MS, NM, ND, RI, SD, UT, VT, WV)
- Brand-name
- Compounded only
How I scored Willow
Every factor here comes from Willow's own pricing, its disclosures and the signup I walked, and the six add up to the 82/100 Mom-Tested Score on the same weighted six-factor method I use on every provider — never nudged by whether a provider pays us.
One of the easiest starts on my list — very little stands between you and a real answer.
Fair, once you've read past the plan structure or an intro rate.
Scores high on medication choice — the options that matter are covered.
Scores low: whether it reaches you is the open question.
Support is the weakest part of this provider's score.
Leaving is about as easy as joining.
How I verified this review
- Last verified
- July 2026
- Confidence
- medium
- Primary source
- www.startwillow.com
$299 and $399, injection or daily tablet, read straight off Willow's own product pages. Thirty-six states — and that list is buried in the Terms rather than shown anywhere you'd look. There's no dose-by-dose table either, so I can't tell you what a higher dose costs.
What to expect when you sign up
I walked Willow's public signup funnel (July 2026) — a first-hand look at the flow. I don't create accounts, enter medical info, or check out, so this is what any visitor sees, not a patient outcome.
- 1Every price is on the public product pages before you start anything — $299 for semaglutide, $399 for tirzepatide, injection or tablet
- 2'Start free visit' hands you to a state-selector first, which is how Willow screens out the fourteen states it doesn't serve
- 3Async health-and-history form — no appointment, no camera, no calendar
- 4A Willow physician reviews it and prescribes if you're eligible; shipping is free and included
What I noticed
- The pricing is refreshingly plain: one number per product, published, with no 'first month $99' bait — rarer than it should be
- It's the only one I looked at that names its doctors — a chief medical officer plus a dozen prescribing physicians on a public page
- The state list lives in the Terms, not on the marketing pages, so you have to go digging to find out whether you're covered
- Willow's own reviews page shows a curated 4.9 out of 5 with nothing negative on it — treat that number as marketing, not measurement
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $299 | InjectionThe published ongoing rate — not a first-month teaser. |
| Compounded tirzepatide | $399 | InjectionAlso the published ongoing rate. |
| Oral semaglutide | $299 | Daily tabletsSame price as the shot, in a once-a-day tablet. |
| Oral tirzepatide | $399 | Daily tabletsNeedle-free tirzepatide, priced level with the injection. |
HSA and FSA usually work for this — worth checking your own plan. The prices here are what Willow's public disclosures showed at last review, and they change often; confirm the current number on Willow's own site.
What I like
- Publishes one plain ongoing price per product — $299 semaglutide, $399 tirzepatide — with no first-month teaser anywhere
- Both molecules come as daily tablets as well as injections, at the same price, if needles are your blocker
- Names a chief medical officer and a dozen prescribing physicians on a public page — almost nobody else here does
- Async intake with no video visit, and you can cancel by message with a full refund before it reaches the pharmacy
The caveats
- December 2025: after a challenge by Novo Nordisk, the National Advertising Division found Willow had not substantiated its compounded-semaglutide safety and efficacy claims and referred it to the FTC and state regulators (NAD case #7488). Willow reports discontinuing the claims since; the referral itself is a matter of record
- The National Advertising Division found its compounded-semaglutide ad claims unsubstantiated, and referred the matter to regulators including state attorneys general when Willow didn't respond (December 2025)
- Only 36 states — and the list is buried in the Terms rather than shown on the marketing pages
- Pricier than most of my shortlist, and no dose-by-dose table to confirm the rate holds as you titrate
- No phone number anywhere — support is chat and email only — and no pharmacy partner is ever named
- Its own reviews page shows a curated 4.9 with no negative reviews on it
What I actually think of Willow
The rare one that just tells you the price and then charges it — $299 or $399, injection or tablet, no first-month bait — and the only one on my list that puts its doctors' names on a public page. It's expensive, it only works in 36 states, and it has an advertising complaint it never answered. It runs about $299/month — pricier than most, so the extras have to earn it.
I look at Willow the way moms actually have to — not just the real monthly number, but nursing and pregnancy timing and canceling without a fight. That's the stuff a generic weight-loss review skips right over.
What Willow really costs
- Compounded semaglutide — Injection: $299/mo
- Compounded tirzepatide — Injection: $399/mo
- Oral semaglutide — Daily tablets: $299/mo
- Oral tirzepatide — Daily tablets: $399/mo
For context, the typical ongoing price across my shortlist is around $179/month, so Willow sits at the pricey end.
Which meds Willow prescribes
Willow prescribes semaglutide and tirzepatide — the two with the strongest published weight-loss numbers, and having both on one account genuinely matters if insulin resistance is in the mix (which it often is with PCOS or after gestational diabetes), because that's when tirzepatide tends to be the better fit. These are compounded from a licensed pharmacy — that's why the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are, and it's worth knowing that going in.
There's a needle-free sublingual option too, which is a relief if injections are the thing stopping you — just set expectations honestly: the under-the-tongue versions are far less studied than the shots the trials actually used.
Who Willow is — and isn't — for
A good fit if…
- you might need to move between semaglutide and tirzepatide as your body and hormones shift.
Look elsewhere if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- you'd rather a prescriber actually talk through nursing and pregnancy timing with you — that's what my #1 pick, CoreAge Rx, is built to do.
Can you trust it?
My confidence is middling — the core facts hold up, but some details (per-state availability, how the program really runs) aren't fully public. With any compounded GLP-1, the most useful thing you can do is confirm which licensed pharmacy fills it and what's actually in the formulation — I explain how I weigh oversight in the scoring method.
A standing caveat, because I'm a mom writing this and not your doctor: GLP-1 meds aren't established as safe during pregnancy or breastfeeding, and every label advises against it. Nothing here changes that — plan the timing with your own clinician.
So, would I use it?
Willow is a reasonable option — weigh it against the picks below on nursing and pregnancy timing and canceling without a fight. For most moms, CoreAge Rx is still the stronger all-round fit — and you can see them side by side in this head-to-head.
The bottom line for moms
Best for: Moms in one of its 36 states who'd rather pay more for a published, no-teaser price and a named prescriber than gamble on a cheap headline that doubles in month two — especially if a daily tablet beats a weekly shot for you.
If Willow isn't the one
Providers I have a referral relationship with, ordered by Mom-Tested Score — highest first. A fee never moves a score, but it does decide who shows up in this box, so it isn't everyone: my full ranking has every provider, paid or not.
- Visit CoreAge RxMom-Tested Score94/100ACoreAge RxMy #1 pick
The one I'd point a friend to first: I finished the intake in a single nap, the price on screen was the price I'd actually pay, and both semaglutide and tirzepatide were right there on one account.
- Visit Pallas HealthMom-Tested Score86/100B+
Pallas is one of the few places that will sell you either the cheap compounded route or the real brand-name pen without making you pick a provider first — compounded semaglutide works out to about $199 a month and tirzepatide about $299, while actual Zepbound, Ozempic, Wegovy and Mounjaro sit alongside them at cash-pay prices from $1,069. The price genuinely doesn't climb as you titrate, Pallas says so plainly on its own site, and the clinician, dose adjustments, check-ins and messaging are all inside that one number with no membership fee stacked on top. Two clinicians are named and both check out in the federal NPI registry, the LegitScript badge it displays is a real one, and it publishes an actual refund policy — full refund if a clinician turns you down, and a $5 processing fee if you cancel a qualifying payment — which is more paperwork than most of this market bothers with. The two things to know before you commit: it bills every 12 weeks in $597 and $897 chunks rather than monthly, and it never names its compounding pharmacy.
- Visit Trimi HealthMom-Tested Score85/100B
The price-first pick: some of the lowest flat, all-inclusive pricing I found, in all 50 states — great if the monthly number is your whole decision and you read the annual-prepay fine print before you sign.
Keep comparing Willow
Head-to-head & alternatives
Willow, answered
- Is Willow's $299 the real price, or does it climb once I'm on a higher dose?
- $299 for semaglutide and $399 for tirzepatide are the numbers Willow publishes on its own product pages, and — unusually for this market — they're presented as the ongoing rate, not a first-month hook you'll regret in thirty days. That part I like. The honest gap is that Willow never publishes a dose-by-dose price table, so I can't tell you from the outside whether the number truly holds as you titrate from a starter dose up to a maintenance one. Several providers on my shortlist say 'flat at any dose' in so many words; Willow doesn't. Ask that question in writing before your first refill, because it's the one that decides what this actually costs you in month five.
- Does Willow work in my state?
- Maybe — and this is the thing to check first, because Willow is not a fifty-state service. Its Terms and Conditions list 36 states. The fourteen it doesn't serve are Alabama, Alaska, Arkansas, Delaware, Kansas, Louisiana, Mississippi, New Mexico, North Dakota, Rhode Island, South Dakota, Utah, Vermont and West Virginia. Worth knowing: the affiliate network we work through lists a longer restriction list that also includes Maine, Massachusetts, Tennessee and Wyoming, but Willow's own legal pages say it operates in all four, so that's what I've gone with. If you're in one of those four, confirm it on the state-selector before you get attached to the price.
- Can I skip the needle with Willow?
- Yes, and it's one of the genuinely useful things here — Willow sells both semaglutide and tirzepatide as once-daily tablets, priced the same as the injections ($299 and $399). If needles are the actual reason you haven't started, that's a real door. The honest caveat I'd want a friend to hear: the trials that produced the weight-loss numbers everyone quotes used the weekly shots, not compounded daily tablets. So it's a convenience option, not a proven equal. If the needle isn't your blocker, the injection is the better-studied route.
- Anything about Willow that would make you hesitate?
- Two things, and neither is about the medicine. First, in December 2025 the National Advertising Division — the ad industry's self-regulatory body — looked at Willow's claims for its compounded semaglutide, decided the evidence behind them didn't hold up because the studies cited were run on the FDA-approved products rather than compounded ones, and asked Willow to change the advertising. Willow didn't respond, so NAD referred it on to regulators including state attorneys general. That's an unresolved advertising matter, not a safety finding, but a company that ignores the referee is telling you something. Second, its own reviews page shows a spotless 4.9 with no negatives, which is curation, not a rating. Neither is a reason to run — Willow names its doctors and publishes its prices, which most of this field won't do — but go in with your eyes open.
Pricing, states and verification reflect Willow's public disclosures at last review; the Mom-Tested Score is one mom's editorial judgment per the published method. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See my medical disclaimer and how I'm funded.